Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. - Wikidata - thesis-toulmin - TriplyDB

Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

http://www.wikidata.org/entity/Q35535322

about

Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications Association of Changes in Mood Status and Psychosocial Well-Being with Depression During Interferon-Based Treatment for Hepatitis C.The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders.A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.The mucosal immune system: master regulator of bidirectional gut-brain communications.Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.Prevalence and correlates of emotional distress in HIV/HCV coinfection.Baseline Comorbidities Enhance the Risk of Treatment-Induced Depression in HCV-Infected Men: A Pilot Study.Birth cohort testing for hepatitis C virus: implications for clinical social workers in health care settings.Imaging the role of inflammation in mood and anxiety-related disorders.Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory.Therapeutic strategies for treatment of inflammation-related depression.The cortisol:C-reactive protein ratio and negative affect reactivity in depressed adults.Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.

P2860

Q26775007-81582BED-1F57-4331-9551-861620AE37C6 Q26798477-6B62243C-AC4F-4CAA-BFEC-A4B034DB41F2 Q30355874-052E5D8C-12CF-439E-9CC8-ACDCB1670D98 Q34665037-A66BAC69-6311-4FBE-A5A2-DB6554EEF5F0 Q35619107-8B5B7106-0CA8-431D-A5FF-C861DCEAB0D0 Q36252032-7837DE48-B1A8-4DCA-B5BA-C74B58C50883 Q36840589-1FF5D323-EB16-46EA-A7A6-D0EAB2B7912E Q37089253-6A8EDF62-81B7-4A06-8985-DF50DF676A01 Q37668003-DBF3C331-7077-4B33-8836-D7B98C43EA14 Q38391718-DE853169-26A7-46C8-AA4E-13208C45EB65 Q42225536-81FF7B26-BBB0-4E12-B5F5-8188606A37AF Q42239297-2C428145-0030-48D7-8021-B0521D6427BF Q42270225-31E5B880-6E0F-4028-922D-83CD51C76B60 Q47305318-DBDE563E-63DF-4DAF-A07D-C0247DAAC675 Q47718372-1D616708-5282-4C8F-9F11-B53113B4AB28 Q47785792-875753B9-B1E1-46CF-AFCB-A0EF3E2ED18C Q47845280-FB76F1B7-E621-48F5-AFBE-9C48615DBB09 Q50198442-D76E167F-F59E-440E-9502-8FDAFBB7BF10

P2860

Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

http://www.wikidata.org/entity/Q35535322

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@ast

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@en

type

label

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@ast

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@en

prefLabel

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@ast

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@en

P1433

Q35535322-DE7B34AC-45F6-4A08-88BD-71066B403744

P1476

Q35535322-43DF9DDB-7E9E-4F3F-8904-7E04C6A169D9

P2093

Q35535322-21568356-7405-48DF-8ACA-8862F8CD2181

Q35535322-452F98B9-0B01-455D-8346-4F5EE667B95A

Q35535322-4D7BDBE5-BDF3-419C-9FD2-BCCB0DAEB14A

Q35535322-5EA54929-41EE-4505-AB71-A4FC0FBEB60B

Q35535322-97AF9452-F8E6-476B-9DCF-AFAAA1137354

Q35535322-B6403364-6190-4F4A-B407-51AC7E14890F

Q35535322-CCE3169B-452E-4574-AF80-5ECEBF99A160

Q35535322-DDF9EE53-DF2E-4742-8682-2C7C33CC9CA0

Q35535322-E8D2D32C-4473-4869-B479-48E3FE8DF805

Q35535322-F34623E1-358D-454B-A241-3E4E9A8C30FF

P2860

Q35535322-000541D4-05D0-45ED-BCF8-2E65C63A79D5

Q35535322-07A67789-6003-41F3-9710-AF6A17CE18FB

Q35535322-0BC706F9-5395-4FF5-9DCD-152F2EDB6BAC

Q35535322-1E4889CC-89EC-40C4-B289-BCC9B79EF624

Q35535322-220456E8-7E12-481D-8810-211F479F1ED5

Q35535322-298D661F-2269-4CB2-8515-7FCCB3062735

Q35535322-2ADB51D2-3626-449F-973F-9C2716C76509

Q35535322-2B2BF147-6FB6-49A1-BDC6-BC3F77CFD761

Q35535322-2DA4E175-4587-46BA-AD3E-E1040F3C34BA

Q35535322-315A2241-441C-409E-B1BF-19106A2AFA70

P304

Q35535322-0BA2756E-F80F-4DD5-9EB8-A3482EC2FFEE

P31

Q35535322-1FAD89FE-5707-4CDD-BCAC-40B11B77E58B

P356

Q35535322-38DD6203-A9DA-488D-BE34-67042DF79DA3

P433

Q35535322-841C6DE9-5A30-41E7-A1AA-DDA34DDAD7E5

P478

Q35535322-95CB06C9-458F-48D4-A424-18557E807609

P577

Q35535322-DFFF3CDE-4F21-4F6E-8FAB-B35C6EC2A54F

P698

Q35535322-253EE345-3361-47D5-BBC0-7D3A65A9B53F

P932

Q35535322-2E9E31E8-8E2B-4122-BC0C-18123E25F7C2

P356

J.JPSYCHORES.2012.10.012

P1433

Journal of Psychosomatic Research

P1476

Vulnerability to somatic sympt ...... : a 16-week prospective study.

@en

P2093

Alexander L Patterson

http://www.w3.org/2001/XMLSchema#string

Aliya Asghar

http://www.w3.org/2001/XMLSchema#string

Benjamin J Morasco

http://www.w3.org/2001/XMLSchema#string

Clare J Wilhelm

http://www.w3.org/2001/XMLSchema#string

Henry McNett

http://www.w3.org/2001/XMLSchema#string

Jennifer M Loftis

http://www.w3.org/2001/XMLSchema#string

Marilyn Huckans

http://www.w3.org/2001/XMLSchema#string

Peter Hauser

http://www.w3.org/2001/XMLSchema#string

Shira Saperstein

http://www.w3.org/2001/XMLSchema#string

Timothy Morgan

http://www.w3.org/2001/XMLSchema#string

P2860

Unipolar late-onset depression: A comprehensive review

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.

Activation of brain macrophages/microglia cells in hepatitis C infection.

The BDNF Val66Met polymorphism is associated with rumination in healthy adults.

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review.

Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.

Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder

Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C.

P304

57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPSYCHORES.2012.10.012

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23272989

http://www.w3.org/2001/XMLSchema#string

P932

4408920

http://www.w3.org/2001/XMLSchema#string